OTCMKTS:SMMNY - Siemens Healthineers Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 15
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$33.70
▲ +0.57 (1.72%)

This chart shows the closing price for SMMNY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Siemens Healthineers Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SMMNY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SMMNY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 15 analysts offering 12 month price targets for Siemens Healthineers in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $33.70.

This chart shows the closing price for SMMNY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 polled investment analysts is to buy stock in Siemens Healthineers. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/20/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/13/2021UBS GroupReiterated RatingNeutral
10/1/2021Societe GeneraleDowngradeBuy ➝ Hold
9/10/2021BarclaysReiterated RatingEqual Weight
9/8/2021Jefferies Financial GroupInitiated CoverageHold
8/2/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/22/2021Societe GeneraleInitiated CoverageBuy
7/15/2021BarclaysReiterated RatingEqual Weight
6/14/2021UBS GroupReiterated RatingNeutral
5/4/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/4/2021Credit Suisse GroupReiterated RatingOutperform
5/4/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
4/30/2021BarclaysReiterated RatingEqual Weight
4/29/2021Berenberg BankReiterated RatingBuy
3/16/2021HSBCUpgradeHold ➝ Buy
2/23/2021UBS GroupReiterated RatingNeutral
2/8/2021Berenberg BankReiterated RatingBuy
2/8/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
1/27/2021Credit Suisse GroupReiterated RatingOutperform
1/20/2021Berenberg BankReiterated RatingBuy
1/12/2021BarclaysReiterated RatingEqual Weight
1/6/2021Stifel NicolausUpgradeHold ➝ Buy
12/9/2020Morgan StanleyUpgradeUnderweight ➝ Overweight
12/9/2020AlphaValueUpgradeReduce
12/3/2020CommerzbankUpgradeHold ➝ Buy
12/3/2020Bank of AmericaUpgradeNeutral ➝ Buy
11/10/2020Credit Suisse GroupReiterated RatingOutperform
10/26/2020Royal Bank of CanadaReiterated RatingSector Perform
10/6/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
8/18/2020UBS GroupReiterated RatingNeutral
8/12/2020BarclaysReiterated RatingEqual Weight
7/24/2020UBS GroupInitiated CoverageNeutral
7/22/2020Royal Bank of CanadaReiterated RatingSector Perform
7/2/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
6/8/2020CitigroupUpgradeNeutral ➝ Buy
5/26/2020Berenberg BankReiterated RatingBuy
5/7/2020Morgan StanleyReiterated RatingUnderweight
5/6/2020Credit Suisse GroupReiterated RatingOutperform
5/6/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
3/31/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
9/19/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Siemens Healthineers logo
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
Read More

Today's Range

Now: $33.70
Low: $33.54
High: $33.79

50 Day Range

MA: $34.04
Low: $31.87
High: $35.75

52 Week Range

Now: $33.70
Low: $21.20
High: $35.90

Volume

31,098 shs

Average Volume

52,767 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Siemens Healthineers?

The following equities research analysts have issued reports on Siemens Healthineers in the last year: AlphaValue, Bank of America Co., Barclays PLC, Berenberg Bank, Commerzbank AG, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, Societe Generale, Stifel Nicolaus, and UBS Group AG.
View the latest analyst ratings for SMMNY.

What is the current price target for Siemens Healthineers?

0 Wall Street analysts have set twelve-month price targets for Siemens Healthineers in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Siemens Healthineers in the next year.
View the latest price targets for SMMNY.

What is the current consensus analyst rating for Siemens Healthineers?

Siemens Healthineers currently has 1 sell rating, 5 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SMMNY will outperform the market and that investors should add to their positions of Siemens Healthineers.
View the latest ratings for SMMNY.

How do I contact Siemens Healthineers' investor relations team?

Siemens Healthineers' physical mailing address is Henkestr. 127, Erlangen, Bayern 91052. The company's listed phone number is (949) 913-1840. The official website for Siemens Healthineers is www.healthcare.siemens.de.